11-93738147-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024116.4(TAF1D):c.421G>A(p.Glu141Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000255 in 1,411,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024116.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF1D | NM_024116.4 | c.421G>A | p.Glu141Lys | missense_variant | 3/6 | ENST00000448108.7 | NP_077021.1 | |
TAF1D | NR_146090.2 | n.622G>A | non_coding_transcript_exon_variant | 3/14 | ||||
TAF1D | NR_146091.2 | n.622G>A | non_coding_transcript_exon_variant | 3/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF1D | ENST00000448108.7 | c.421G>A | p.Glu141Lys | missense_variant | 3/6 | 5 | NM_024116.4 | ENSP00000410409.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000255 AC: 36AN: 1411582Hom.: 0 Cov.: 31 AF XY: 0.0000271 AC XY: 19AN XY: 701088
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.421G>A (p.E141K) alteration is located in exon 3 (coding exon 2) of the TAF1D gene. This alteration results from a G to A substitution at nucleotide position 421, causing the glutamic acid (E) at amino acid position 141 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at